Oscar Escalona Rayo
Onderzoeker
- Naam
- O. Escalona Rayo MSc
- Telefoon
- 071 5272727
- o.escalona.rayo@lic.leidenuniv.nl
Onderzoeker
- Faculteit der Wiskunde en Natuurwetenschappen
- LIC
- Chemistry for Human Health
- Supramolecular & Biomaterials Chemistry
Promovendus
- Faculteit der Wiskunde en Natuurwetenschappen
- LIC
- Chemistry for Human Health
- Supramolecular & Biomaterials Chemistry
- Escalona Rayo O. (20 januari 2026), Lipid nanoparticle technology for mRNA delivery: bridging vaccine applications with fundamental insights into nano-bio interactions (Dissertatie. Leiden Institute of Chemistry (LIC), Faculty of Science, Leiden University). Promotor(en): Kros A., Jiskoot W. & Slütter B.A.
- Ostroumov D., Benne N., Lozano Vigario F., Escalona-Rayo O., Dodz K., Sauer S., Suhl L.L., Wedemeyer H.H., Kühnel F., Slütter B.A. & Wirth T.C. (2025), Sequential STING and CD40 agonism drives massive expansion of tumor-specific T cells in liposomal peptide vaccines, Cellular & Molecular Immunology 22(2): 150-160.
- Escalona Rayo O., Papadopoulou P., Slutter B.A. & Kros A. (2024), Biological recognition and cellular trafficking of targeted RNA-lipid nanoparticles, Current Opinion in Biotechnology 85: 103041.
- Zeng Y., Escalona-Rayo O., Knol R.A., Kros A. & Slütter B.A. (2023), Lipid nanoparticle-based mRNA candidates elicit potent T cell responses, Biomaterials Science 11(3): 964-974.
- Escalona Rayo O., Zeng Y., Knol R.A., Kock T.J.F., Aschmann D., Slütter B.A. & Kros A. (2023), In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy, Biomedicine & Pharmacotherapy 165: 115065.
- Strien J. van, Escalona-Rayo O.,Jiskoot W., Slütter B. & Kros A. (2022), Elastin-like polypeptide-based micelles as a promising platform in nanomedicine, Journal of Controlled Release 353: 713-726.